Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 12, 2017
Pharmacy Choice - News - Generic Drugs - December 12, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 60     Next >>     Go To Page:

12/12/17 - Alembic Pharma gains on USFDA approval for Darifenacin [India Infoline News Service]
Alembic Pharmaceuticals Limited today announced that the company has received approval from the US Food and Drug Administration for its Abbreviated New Drug Application Darifenacin Extended- Release Tablets, 7.5 mg and 15 mg. Alembic Pharmaceuticals, a leading pharmaceutical company, is a market leader in the macrolides segment of anti-infective dr
12/12/17 - CREATES Act supporters look for help to lower drug prices [The Buffalo News, N.Y.]
The legislation prevents brand drug manufacturers from blocking cheaper generic drugs from coming to market, and enjoys support from a bipartisan group of senators including Republicans Mike Lee, John McCain and Chuck Grassley, and Democrats Dianne Feinstein and Patrick Leahy, among others. "President Trump, Republicans, and Democrats have all voi
12/12/17 - Determination That NOROXIN (Norfloxacin) Tablets, 400 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
This determination will allow FDA to approve abbreviated new drug applications for norfloxacin tablets, 400 mg, if all other legal and regulatory requirements are met. The 1984 amendments include what is now section 505 of the Federal Food, Drug, and Cosmetic Act, which requires FDA to publish a list of all approved drugs. Under FDA regulations, dr
12/12/17 - Generic Viagra arrives at 50% price Generic Viagra arrives at a 50% savings
Pfizer, the maker of Viagra, introduced the first official generic version of its impotence pill Monday. The drug costs $30 to $35 per pill, about half the price of brand-name Viagra. Some of the lowest consumer prices for generic Viagra are already offered by specialized pharmacies and e-commerce startups, such as New York- based Roman Health, whi
12/12/17 - Impax Receives Tentative FDA Approval of Generic Coreg CR Extended-Release Capsules
BRIDGEWATER, N.J.- Impax Laboratories, Inc., a specialty pharmaceutical company, today announced it has received tentative U.S. Food and Drug Administration approval on its Abbreviated New Drug Application for a generic version of Coreg CR extended-release capsules, 10, 20, 40 and 80 mg. Impax Laboratories, Inc. is a specialty pharmaceutical compan
12/12/17 - New generic Viagra is here, cutting pharmacy bills for Michigan men in search of erections [Detroit Free Press]
Pfizer, the maker of Viagra, on Monday introduced the first official generic version of its blockbuster impotence pill. Some of the lowest consumer prices for generic Viagra are already offered by specialized pharmacies as well as new e-commerce startups, such as New York- based Roman Health, which has an online prescription service and mail-order
12/12/17 - Novartis - Sandoz announces new Phase I data showing proposed biosimilar pegfilgrastim matches reference medicine
Holzkirchen- Sandoz, a division of Novartis and the global leader in biosimilars, today announced data demonstrating the pharmacokinetics, pharmacodynamics, safety and immunogenicity of proposed biosimilar pegfilgrastim as compared to the reference biologic, Neulasta. The Phase I study, conducted in healthy volunteers, confirmed that Sandoz biosimi
12/12/17 - supply of Generic Drugs [TenderNews.com - Tenders (India)]
supply of Generic Drugs more info: Location: Brazil BidDate: 12/20/2017 Tender Country: Brazil Tender Type: Tenders Tendering Authority: GOVERNMENT OF THE STATE OF PARA Tendering Authority Address: GOVERNMENT OF THE STATE OF PARA Financier: Self Funded Tearn Money: Not Specified.
12/11/17 - Daiichi Sankyo's Subsidiary Daiichi Sankyo Espha to Launch New Generic Drugs
Tokyo, Japan- Daiichi Sankyo Company, Limited today announced that its generics subsidiary, Daiichi Sankyo Espha Co., Ltd. will launch in Japan 4 new generic drugs with 2 active ingredients on December 8, 2017, that were announced in the official gazette today. OD Tablets and will be additional formulations with the same ingredient to Rosuvastatin
12/11/17 - Elorac, Inc. to Market a New Low-Cost Line of Sodium Sulfacetamide/Sulfur Topical Products
Elorac, Inc. announced today that it plans to introduce a low-cost line of generic sodium sulfacetamide/sulfur topical formulations for the treatment of acne, rosacea and seborrheic dermatitis. Elorac, Inc. is a privately owned, specialty pharmaceutical company engaged in the development and commercialization of novel products for dermatology, alle
12/11/17 - Global Biosimilar Monoclonal Antibodies Market Revenue CAGR to Exceed 35.7% - Marketresearch.biz
MarketResearch.biz announces publication of its most recently generated research report titled, " Global Biosimilar Monoclonal Antibodies Market by Drug Class, Application, and Region- Global Forecast to 2026", which offers a holistic view of the global biosimilar monoclonal antibodies market through systematic segmentation that covers every aspect
12/11/17 - Lannett Announces Agreement For Authorized Generic Version Of Toprol-XL
By a News Reporter-Staff News Editor at Pharma Business Week Lannett Company, Inc. announced that it has entered into an agreement with Aralez Pharmaceuticals Trading DAC, an Irish designated activity company, to become the exclusive distributor in the U.S. of the authorized generic version of Toprol-XL Extended Release Tablets in 25 mg, 50 mg
12/11/17 - Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry
By a News Reporter-Staff News Editor at Pharma Business Week Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver "first to file" results to generic drug companies around the globe, allowing them to bring affordable healthcare to more and more patients throughout the world. Inspected by the FDA, WHO, Hea
12/11/17 - One way to slash drug prices: Leave insurance card at home [Qatar Tribune]
Patrik Swanljung found this out when he went to fill a prescription for a generic cholesterol drug. In May, Swanljung handed his Medicare prescription card to the pharmacist at his local Walgreens and was told that he owed $83.94 for a three-month supply. Alarmed at that price, Swanljung went online and found Blink Health, a startup, offering the s
12/11/17 - Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo 32mg Extended Release Tablets
By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc announced the launch of an AB rated generic version of Exalgo 32 mg extended release tablets C-II. Annual market sales for the brand and generic equivalents of Exalgo 32 mg extended release tablets for the 12 months ended September 2017 were approximately $32 m
12/11/17 - Perrigo Announces the Launch of an AB Rated Generic Version of Mycolog II Cream
By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc announced the launch of an AB rated generic version of Mycolog II Cream. Annual market sales for the generic versions of Mycolog II Cream for the 12 months ended September 2017 were approximately $81 million according to IMS Health. Keywords for this news artic
12/11/17 - Teva Announces Exclusive Launch of Generic Viagra Tablets in the United States
Teva Pharmaceutical Industries Ltd., today announced the exclusive launch of its generic Viagra 1 tablets in the U.S.. The launch of Teva s sildenafil tablets brings an affordable generic treatment option to the estimated 18 million men in the U.S. who are diagnosed with erectile dysfunction, said Brendan O Grady, Executive Vice Pres
12/11/17 - Teva Dismisses Litigation After Mylan Wins U.S. Court Ruling Related to Teva's Cold Filtration Patents for Copaxone 40 mg/mL
HERTFORDSHIRE, England and PITTSBURGH, Dec. 11, 2017/ PRNewswire/ Mylan N.V. today announced that Teva has dismissed its pending district court litigation against Mylan regarding Mylan's Glatiramer Acetate Injection 40 mg/mL, the first generic version of Copaxone 40 mg/mL. The litigation involved two non-Orange Book listed patents, U.S. Patent
12/11/17 - Top UK university hospital unveils data that support the use of rapid infusion for Truxima (CT-P10, biosimilar rituximab) in patients with advanced-stage follicular lymphoma
New data from University College London Hospitals NHS Foundation Trust on the safety and tolerability of rapid infusion of CT-P10 were presented this weekend at the 59 th American Society of Hematology Annual Meeting. Simon Cheesman from the University College London Hospitals NHS Foundation Trust and one of the authors of the study said, We fel
12/11/17 - Upsher-Smith Launches KLOR-CON Powder Potassium Chloride For Oral Solution
By a News Reporter-Staff News Editor at Pharma Business Week Upsher-Smith Laboratories, LLC. announced the launch of KLOR-CON Powder for oral solution, 20 mEq. The Company received approval of an abbreviated new drug application from the U.S. Food and Drug Administration for this product, which will be marketed and distributed by Upsher-Smith.
12/9/17 - Biocon gets shareholders nod for transfer of biosimilars business [Arab Finance (Egypt)]
Biotechnology major Biocon said it has received shareholders approval to the resolution for transfer of biosimilars business by way of a slump sale to group entity Biocon Biologics India. The resolution for transfer of Biosimilars business of the company by way of a slump sale as Going Concern to Biocon Biologics India Ltd... has been passed by the
12/9/17 - Generic Drug Market: Global Generic Drug Share to Surpass USD 380.60 Billion by 2021: Zion Market Research, the market research group announced the analysis report titled 'Generic Drug Market: Global Industry Analysis, Size, Share, Growth, Trends, an
Sarasota, FL 12/08/2017 Zion Market Research has published a new report titled " Generic Drug Market by Brand for Central Nervous System, Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications- Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 2021". According to the report, the global g
12/9/17 - Generic Viagra to hit the market [The Pittsburgh Tribune-Review]
Drugmaker Pfizer Inc. will begin selling the generic version, in white pill form, for about $32 a pill, half of Viagra's price. Pfizer negotiated a deal four years ago allowing Teva Pharmaceuticals USA Inc. to begin selling a generic version in the United States on Monday, Forbes reported. Therefore, Pfizer plans to release its own white pill at ha
12/9/17 - Researchers' Work from Brigham and Women's Hospital and Harvard University School of Medicine Focuses on Generics (Generic Versions of Narrow...
Researchers' Work from Brigham and Women's Hospital and Harvard University School of Medicine Focuses on Generics. Funders for this research include FDA Office of Generic Drugs and Office of Chief Scientist, Robert Wood Johnson Foundation Public Health Law Research program. Our news journalists obtained a quote from the research from the Brigham an
12/9/17 - Sandoz announces new Phase I data showing proposed biosimilar pegfilgrastim matches reference medicine [Sudan Tribune]
-Phase I study demonstrates matching pharmacokinetic, pharmacodynamic, safety and immunogenicity profiles of Sandoz biosimilar pegfilgrastim and reference medicine. Holzkirchen, 08 December 2017- Sandoz, a division of Novartis and the global leader in biosimilars, today announced data demonstrating the pharmacokinetics, pharmacodynamics, safety and
Articles(s): 1 - 25 of 60     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415